PGNY stock forecast
Our latest prediction for Progyny, Inc.'s stock price was made on the Aug. 6, 2020 when the stock price was at 27.28$.
In the short term (2weeks), PGNY's stock price should underperform the market by -1.17%. During that period the price should oscillate between -8.56% and +7.61%.
In the medium term (3months), PGNY's stock price should underperform the market by -5.93%. During that period the price should oscillate between -30.66% and +22.16%.Get email alerts
Create a solid portfolio with PGNY
About Progyny, Inc.
Progyny, Inc. is a medical device company. It engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. The firm operates through the following segments: medical device and fertility benefits solution. The company's services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
At the moment the company generates 264M USD in revenues.
On its last earning announcement, the company reported a loss of -0.05$ per share.
The book value per share is 1.35$
Three months stock forecastAug. 6, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|